Clinical Trials
11 trialsNCT04468919 2025-05-16
BCI-FIT
Oregon Health and Science University
Phase NA Completed
NCT03516994 2024-05-16
EQUALACP
Duke University
Phase NA Completed
NCT02118805 2024-04-16
QUESST
Beth Israel Deaconess Medical Center
Completed
NCT03042416 2022-01-10
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
University of Alberta
Phase 3 Completed
NCT03847753 2020-05-22
COMO-GMC
University of Aarhus
Completed
NCT02819011 2020-02-27
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Baylor College of Medicine
Phase 2 Completed
NCT02761707 2019-07-18
Biomarkers in Neural Disorders
University of Pennsylvania
Completed
NCT01691924 2016-03-08
Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 1 Completed
NCT02111330 2016-03-08
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 1 Completed
NCT02015806 2016-01-11
REMIND
Brigham and Women's Hospital
Phase NA Completed
NCT01698450 2014-10-09
Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders
University Children's Hospital, Zurich
Phase 1 Completed